Finance

Lists
506690:BOM
Unichem Laboratories Ltd
512,75 INR
-1,41%
(-7,35) 1D
16 ოქტ, 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 506690...
Open
520,60 INR
High
521,65 INR
Low
505,00 INR
Mkt. cap
35,95 მლრდ.
Avg. vol.
12,66 ათ.
Volume
2,22 ათ.
P/E ratio
11,86
52-wk high
685,95 INR
52-wk low
280,00 INR
EPS
43,22 INR
Shares outstanding
70,38 მლნ.
No. of employees
3 ათ.
Open
520,60 INR
High
521,65 INR
Low
505,00 INR
Mkt. cap
35,95 მლრდ.
Avg. vol.
12,66 ათ.
Volume
2,22 ათ.
P/E ratio
11,86
52-wk high
685,95 INR
52-wk low
280,00 INR
EPS
43,22 INR
Shares outstanding
70,38 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
The Fintech Times
The Fintech Times
·
36 წუთის წინ
First Digital to List on Nasdaq via SPAC Deal at $250m Valuation
Bloomberg.com
Bloomberg.com
·
4 საათის წინ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
Unichem Laboratories is an Indian pharmaceutical company, headquartered in Mumbai. It manufactures and markets pharmaceutical formulations across the globe, including the regulated markets of the USA and Europe. Wikipedia
About Unichem Laboratories Ltd
CEO-
Employees2,78 ათ.
Founded1944
Headquartersმუმბაი, მაჰარაშტრა, ინდოეთი
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
5,79 მლრდ.
5,21 მლრდ.
5,75 მლრდ.
6,33 მლრდ.
Cost of goods sold
2,70 მლრდ.
2,37 მლრდ.
3,41 მლრდ.
2,89 მლრდ.
Cost of revenue
2,70 მლრდ.
2,37 მლრდ.
3,41 მლრდ.
2,89 მლრდ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,00 მლრდ.
992,70 მლნ.
1,05 მლრდ.
1,03 მლრდ.
Operating expense
2,74 მლრდ.
2,71 მლრდ.
2,10 მლრდ.
3,04 მლრდ.
Total operating expenses
5,44 მლრდ.
5,08 მლრდ.
5,50 მლრდ.
5,93 მლრდ.
Operating income
347,10 მლნ.
135,30 მლნ.
246,30 მლნ.
400,00 მლნ.
Other non operating income
209,70 მლნ.
118,00 მლნ.
-389,10 მლნ.
156,10 მლნ.
EBT including unusual items
-108,20 მლნ.
2,93 მლრდ.
187,90 მლნ.
489,90 მლნ.
EBT excluding unusual items
474,40 მლნ.
179,10 მლნ.
271,70 მლნ.
489,90 მლნ.
Income tax expense
10,70 მლნ.
291,40 მლნ.
78,80 მლნ.
75,20 მლნ.
Effective tax rate
-9,89%
9,93%
41,94%
15,35%
Other operating expenses
1,42 მლრდ.
1,40 მლრდ.
743,50 მლნ.
1,71 მლრდ.
Net income
-118,90 მლნ.
2,64 მლრდ.
109,10 მლნ.
414,70 მლნ.
Net profit margin
-2,05%
50,71%
1,90%
6,56%
Earnings per share
-
-
-
-
Interest and investment income
-
-
53,00 მლნ.
-
Interest expense
-82,40 მლნ.
-74,20 მლნ.
-92,80 მლნ.
-66,20 მლნ.
Net interest expenses
-82,40 მლნ.
-74,20 მლნ.
-39,80 მლნ.
-66,20 მლნ.
Depreciation and amortization charges
314,70 მლნ.
312,50 მლნ.
306,10 მლნ.
299,40 მლნ.
EBITDA
663,40 მლნ.
428,72 მლნ.
541,10 მლნ.
694,80 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google აპები